Truist bullish on diabetes companies citing potential market growth
Source: SeekingAlpha
2025-06-16 11:24:21 ET
More on DexCom, Insulet, Tandem
- Tandem Diabetes Care: A Barbell Bet On A High-Stakes Turnaround
- Insulet Corporation: Shares Remain Astronomically Expensive
- DexCom Q1 Earnings: Organic Revenue Growth Versus Cost Pressure
- Tandem, Abbott in deal to combine insulin delivery with glucose-ketone sensor
- Tandem to pay Roche $36M in patent dispute settlement
Read the full article on Seeking Alpha
For further details see:
Truist bullish on diabetes companies citing potential market growth
Insulet Corporation
NASDAQ: PODD
PODD Trading
1.18% G/L:
$239.48 Last:
234,118 Volume:
$241.86 Open:
PODD Latest News
July 08, 2025 06:00:00 am
Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025
June 19, 2025 06:00:00 am
Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions
June 10, 2025 08:30:00 am
Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users
PODD Stock Data
$17,809,372,432
69,643,429
0.03%
360
N/A
Medical Equipment & Supplies
Healthcare
US
Acton
